Since the past year, a black box warning label has marked Reglan as one of the most dangerous prescription drugs on the market. However, the label does not address studies that prove that Reglan does not even live up to its expectations as an effective drug.

The Food & Drug Administration originally approved Reglan in 1979 to combat gastrointestinal problems, especially gastroparesis and gastroesophageal reflex disease. While it took 30 years to issue the black box label to warn patients about possible complications, it did not take 30 years to publish a study to prove that the drug had minimal effectiveness to match its dangerousness.

Studies published in 1975, 1983, and 2006 all pointed to weak or non-existent responses to the drug treatment. In comparison, 1983, 1984, and 1992 saw studies pointing out the risks of Reglan.

Reglan is only supposed to be taken for short-term treatment of gastrointestinal ailments, but has been proven to be ineffective for many of the most needy patients suffering from these disorders.

If you or someone you love has been diagnosed with tardive dyskinesia due to Reglan use, you may be entitled to compensation for your medical bills and suffering. Contact the Reglan tardive dyskenesia lawsuit attorneys of Williams Kherkher today by calling 800-761-3187.